Bioceres Crop Solutions Corp. (NASDAQ:BIOX)
| Market Cap | 21.35M-74.2% |
| Revenue (ttm) | 237.80M |
| Net Income | -46.90M |
| EPS | -0.74 |
| Shares Out | 63.82M |
| PE Ratio | n/a |
| Forward PE | 0.52 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 130,775 |
| Open | 0.34 |
| Previous Close | 0.34 |
| Day's Range | 0.32 - 0.35 |
| 52-Week Range | 0.30 - 2.19 |
| Beta | 0.47 |
| Analysts | none |
| Price Target | n/a |
| Earnings Date | Nov 12, 2026 |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About BIOX
Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Brazil, North America, Europe, the Middle East, South America, the United States, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.
$BIOX stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in BIOX holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by BIOX's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
BIOX Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New BIOX patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to BIOX from public contracts
Source: USAspending.gov
BIOX Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from BIOX’s recent data — informational, not investment advice